Journal of the European Academy of Dermatology and Venereology · 2007 · 33 citations · 9 references
MedicineDermatologyImmunologyDermatopathologyHypersensitivityImmunotherapyInfectious DermatosesInflammatory Skin DiseasesInflammatory Skin DisordersSkin SafetyClinical Score EvaluationDermatologic Corticosteroid TherapyOutcome MeasuresSeborrheic EczemaTopical Antifungal AgentsTopical Corticosteroid PreparationsTopical CreamsTreatment With Topical Corticosteroids
BACKGROUND: Seborrhoeic dermatitis (SD) is a common dermatosis in human immunodeficiency virus (HIV)-positive patients, many of whom do not respond satisfactorily to conventional topical treatments such as corticosteroids and antifungals. OBJECTIVE: A pilot study to investigate the efficacy and tolerability of pimecrolimus cream 1% in HIV-positive patients with facial SD. METHODS: In a single-centre study, 21 HIV-infected patients with mild to severe SD were treated twice daily with pimecrolimus cream 1% for 14 days. Thereafter, treatment was discontinued and patients followed up for 5 weeks. Skin involvement at baseline and on days 7, 14, 21, 35 and 49 was assessed using a four-point clinical score and digital photography. MAIN OUTCOME MEASURES: Efficacy and safety of pimecrolimus cream 1% treatment and incidence of relapse in the follow-up phase. Results Marked improvement was seen in clinical parameters at day 7, with >or= 90% patients clear of symptoms at day 14. Relapse was observed at day 35 but signs were milder than at baseline. All patients responded to therapy, despite their immunological status. Pimecrolimus did not alter CD4(+) and CD8(+) T-cell counts or viral load during the treatment period. CONCLUSION: Pimecrolimus cream represents a new, effective therapeutic option for facial SD in HIV patients.
9
Fitzpatrick’s Dermatology in General Medicine
Heart & Lung · 1999 · 3.3K citations
Steven Kempers, Mark Boguniewicz, Eric Carter et al. · Journal of the American Academy of Dermatology · 2004 · 120 citations
Medicine, Dermatology, Pediatrics +14
Dimitris Rigopoulos, D. Ioannides, D. Kalogeromitros et al. · British Journal of Dermatology · 2004 · 96 citations · Full text
Pimecrolimus: a new treatment for seborrheic dermatitis.
Charles E. Crutchfield · PubMed · 2002 · 46 citations